Skip to main content
Rana Jawish

Rana Jawish, MD

Languages spoken: English

Clinical Locations

525 Plaza

HMHI (UNI) Downtown Behavioral Health Clinic
801-585-1212
  • Rana Jawish, MD, is an Assistant Professor in the Department of Psychiatry and an Adjunct Assistant Professor in the Division of Epidemiology, Department of Medicine, University of Utah Spencer Fox Eccles School of Medicine. Her clinical interest is in improving women’s mental health and expanding access to mental health care for pregnant women with substance use and mood disorder. Her research advances innovative neuromodulation modalities including Transcranial Magnetic Stimulation (TMS) for the treatment of perinatal substance use and mood disorder with a specific focus in developing a breakthrough treatment to address the ongoing epidemic of methamphetamine use disorder and to improve morbidity and mortality in pregnant women with methamphetamine use disorder and mood disorder. She is also interested in identifying existing barriers and factors that are facing this underserved, vulnerable, understudied patient population. Dr. Jawish is board-certified in Psychiatry and board-eligible in Addiction Psychiatry with the American Board of Psychiatry and Neurology. Dr. Jawish has recently been named a member of the VPCAT Scholar program for the 2024-2025 cohort.

    Board Certification

    American Board of Psychiatry & Neurology (Psychiatry)
    Educational Commission for Foreign Medical Graduates
  • Rana Jawish, MD, is an Assistant Professor in the Department of Psychiatry and an Adjunct Assistant Professor in the Division of Epidemiology, Department of Medicine, University of Utah Spencer Fox Eccles School of Medicine. Her clinical interest is in improving women’s mental health and expanding access to mental health care for pregnant women with substance use and mood disorder. Her research advances innovative neuromodulation modalities including Transcranial Magnetic Stimulation (TMS) for the treatment of perinatal substance use and mood disorder with a specific focus in developing a breakthrough treatment to address the ongoing epidemic of methamphetamine use disorder and to improve morbidity and mortality in pregnant women with methamphetamine use disorder and mood disorder. She is also interested in identifying existing barriers and factors that are facing this underserved, vulnerable, understudied patient population. Dr. Jawish is board-certified in Psychiatry and board-eligible in Addiction Psychiatry with the American Board of Psychiatry and Neurology. Dr. Jawish has recently been named a member of the VPCAT Scholar program for the 2024-2025 cohort.

    Board Certification and Academic Information

    Academic Departments Psychiatry -Primary
    Internal Medicine -Adjunct
    Academic Divisions Adult Psychiatry
    Epidemiology
    Board Certification
    American Board of Psychiatry & Neurology (Psychiatry)
    Educational Commission for Foreign Medical Graduates

    Education history

    Fellowship Addiction Psychiatry - University of Utah School of Medicine, Huntsman Mental Health Institute Fellow
    General Psychiatry Program - University of Utah School of Medicine, Huntsman Mental Health Institute Chief Resident
    Residency General Psychiatry Program-Research Track - University of Utah School of Medicine, Huntsman Mental Health Institute Resident
    Psychiatry - University of Minnesota Medical School Resident
    Internship Clinical Pain Management - Cincinnati Comprehensive Pain Center Intern
    Maternal Fetal Medicine - Cincinnati Children's Fetal Care Center Clinical Research Fellow
    Residency Obstetrics & Gynecology - Syrian Ministry of Health State Hospitals Resident
    Medicine - Damascus University School of Medicine M.D.

    Selected Publications

    Journal Article

    1. Tadler SC, Jones KG, Lybbert C, Huang JC, Jawish R, Solzbacher D, Kendrick EJ, Pierson MD, Weischedel K, Rana N, Jacobs R, Vonesh LC, Feldman DA, Larson C, Hoffman N, Jessop JE, Larson AL, Taylor NE, Odell DH, Kuck K, Mickey BJ (2023). Propofol for treatment resistant depression: A randomized controlled trial. (Read full article)
    2. Endres L, DeFranco E, Conyac T, Adams M, Zhou Y, Magner K, ORourke L, Bernhard KA, Siddiqui D, McCormick A, Abramowicz J, Merkel R, Jawish R, Habli M, Floman A, Magann EF, Chauhan SP, CAOG FAR Research Network (2015). Association of Fetal Abdominal-Head Circumference Size Difference With Shoulder Dystocia: A Multicenter Study. AJP Rep, 5(2), e099-104. (Read full article)
  • News & Podcasts